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Abstract
Background: Dengue and leptospirosis infections are currently two major endemics in Malaysia. Owing to the
overlapping clinical symptoms between both the diseases, frequent misdiagnosis and confusion of treatment
occurs. As a solution, the present work initiated a pilot study to investigate the incidence related to co-infection of
leptospirosis among dengue patients. This enables the identification of more parameters to predict the occurrence of
co-infection.
Method: Two hundred sixty eight serum specimens collected from patients that were diagnosed for dengue fever were
confirmed for dengue virus serotyping by real-time polymerase chain reaction. Clinical, laboratory and demographic data
were extracted from the hospital database to identify patients with confirmed leptospirosis infection among the dengue
patients. Thus, frequency of co-infection was calculated and association of the dataset with dengue-leptospirosis
co-infection was statistically determined.
Results: The frequency of dengue co-infection with leptospirosis was 4.1%. Male has higher preponderance of
developing the co-infection and end result of shock as clinical symptom is more likely present among co-infected
cases. It is also noteworthy that, DENV 1 is the common dengue serotype among all cases identified as dengue-
leptospirosis co-infection in this study.
Conclusion: The increasing incidence of leptospirosis among dengue infected patients has posed the need to
precisely identify the presence of co-infection for the betterment of treatment without mistakenly ruling out
either one of them. Thus, anticipating the possible clinical symptoms and laboratory results of dengue-leptospirosis
co-infection is essential.
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Background
Dengue fever and leptospirosis infections have emerged
as an important concern of public health worldwide,
particularly in tropical and subtropical regions. Dengue
fever is an arthropod born viral disease [1] whereas
leptospirosis is a zoonotic disease caused by the spiro-
chetes of the genus Leptospira [2].
Often, dengue and leptospirosis are diagnosed sepa-
rately. The gold standard test to identify leptospira is the
microscopic agglutination test (MAT) while IgM anti-
body detection by using enzyme-linked immunosorbent
assay (ELISA) is also widely used nowadays [3]. Further,
the confirmatory test for dengue is known as dengue
combo test which includes the detection of dengue im-
munoglobulin M (IgM) and immunoglobulin G (IgG)
serology with non-structural 1 (NS1) antigen [4]. Addi-
tionally, molecular diagnosis by using the Real-Time
Polymerase Chain Reaction (Rea-Time PCR) is also per-
formed concurrently with serology for confirmation and
detection of dengue virus.
In the recent years, co-infections of dengue cases with
leptospirosis have been reported with frequency ranging
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from 0.9-8% [5–7]. Both the infections generally present
with a phase of acute febrile illness which includes the
sudden onset of fever, headache, and myalgia [8]. Due to
the overlapping clinical presentations between these two
diseases, ability to diagnose them became more challen-
ging especially with the presence of acute co-infection. It
is very crucial to be able to distinguish leptospirosis from
dengue as early commencement of antibiotic therapy in
cases with leptospirosis leads to a more favorable out-
come, while dengue can be treated symptomatically [9].
Therefore, we designed a retrospective study, aiming
to screen the patients that were admitted for dengue
fever at Hospital Serdang and to determine the preva-
lence of co-infection with leptospirosis. Other than that,
this study also attempts to identify the clinical predictors
of both the co-infection.
Methods
Study subject
In this study, serum specimens were obtained from a
total of 268 randomly selected patients that were admit-
ted primarily for dengue fever at Hospital Serdang,
Malaysia in between 2014-2016. Clinical, demographic
and laboratory data were retrieved from the patients’
database available in the hospital. Besides, leptospirosis
laboratory testing (performed by hospital) were also re-
corded for those dengue patients who were also sus-
pected for leptospirosis infection.
Dengue viral RNA extraction
Dengue viral ribonucleic acid (RNA) was extracted from
the serum specimens by using the QIAamp Viral RNA
Mini Kit (Qiagen) following the manufacturer’s instruc-
tions. During the final procedure of the spin column
based method, 50 μl of viral RNA was eluted from each
serum specimen. This were then used as template for
the one-step Real-Time PCR amplification.
Serotyping by Multiplex Real-Time PCR
Subsequently, extracted dengue viral RNAs were sub-
jected for serotyping by using the commercially available
abTES DEN 4 qPCR I kit (AITbiotech). The PCR reac-
tions are composed of 12.5 µl of 2X RT (reverse transcrip-
tase)-PCR Mix, 1.5 μl of Primer/Probe Mix, 0.5 μl of RT/
Taq Enzyme Mix, 0.1 μl of Internal Control, 5.0 μl of RNA
template and 5.4 μl of nuclease-free water. As for the
negative control, the RNA template was replaced with 5 μl
of nuclease-free water. Real-Time PCR amplification was
performed on the CFX 96 (Biorad) platform with the cyc-
ling condition recommended by the manufacturer.
Data analysis
The study subjects were categorized into two groups,
namely dengue-leptospirosis co-infection and dengue
infection without leptospirosis. Statistical analysis was
done by using the IBM statistical package for the social
sciences (SPSS) version 21.0. Categorical data were re-
ported in terms of proportions (percentage). Chi-square
test was used for the categorical variables. Further, mul-
tiple logistic regression analysis was used to identify the
clinical predictors of dengue-leptospirosis co-infection.
Variables with the p value less than 0.25 in univariate
analysis square test as well as all other clinically significant
variables were entered into the multiple logistic regres-
sions. The dependent variable was dengue-leptospirosis
co-infection while the selected independent variables for
multiple logistic regressions were gender, shock, lethargy
and abdominal pain. All analyses were made with 95%
confidence interval (CI), and the level of significance was
set at p < 0.05.
Results
Dengue virus serotypes and prevalence of dengue-
leptospirosis co-infection
The Real-Time PCR assay detects the dengue virus
based on the four fluorescence channels and one addi-
tional channel for internal control. The channels that
were used are Cy5 (DENV 1), FAM (DENV 2), Texas
red (DENV 3), Quasar 705 (DENV 4) and HEX for the
internal control. From the total of 268 dengue fever
cases that were included in this study, the prevalence of
dengue serotypes were DENV 1 (67.5%), DENV 2
(15.7%), DENV 3 (6.3%), dual infections of DENV 1/2
(7.1%), DENV 1/3 (1.9%), DENV 2/3 (1.1%) and DENV
2/4 (0.4%). For those dengue patients that were sus-
pected for leptospirosis, the hospital proceeded with fur-
ther test, the IgM assay. Additionally, the reference
laboratory conducted the MAT (Table 1). Based on the
data obtained from the laboratory investigation, 11
(4.1%) dengue cases out of the total 268 cases were
found to be co-infected with leptospirosis. Although no
significant association were found between the dengue
serotypes and the leptospirosis co-infection, it is note-
worthy that all the 11 co-infected cases belongs to the
serotype DENV 1.
Association of age and gender with dengue-leptospirosis
co-infection
The association between the demographic data such as
age and gender among cases of dengue fever with lepto-
spirosis and non-leptospirosis groups among the study
population was analyzed. There was no significant asso-
ciation found between age and the two groups with the
mean of 32.3 ± 9.4 and 30.8 ± 10.8 respectively. Besides
that, gender was proven to be significantly associated
with the outcome of co-infection whereby male patients
were more likely to develop dengue fever with leptospi-
rosis compared to female patients (P = 0.03).
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Association of clinical symptoms with dengue-leptospirosis
co-infection
The association between the various spectrums of clinical
symptoms and presentation with dengue-leptospirosis co-
infection was investigated and tabulated in Table 2. The
outcome of the analysis showed that shock was a significant
symptoms that was shared in common by patients pre-
sented with dengue-leptospirosis co-infection (P = 0.001).
Other than that, vomiting was seen more often among the
cases of dengue fever alone rather than dengue with lepto-
spirosis co-infection. As well, symptoms such as headache,
arthralgia, epigastric pain, retro-orbital pain, acute kidney
injury, gum bleeding, hepatitis and bleeding tendency were
predominantly seen among the cases of dengue fever alone
while absent in the dengue-leptospirosis group. On top of
that, it was also found that frequency of abdominal pain
and lethargy were higher and more specific to the dengue-
leptospirosis group. Also, a minor difference was seen in
terms of number of days of onset of fever between the co-
infection and non-co-infection groups with an average of
4.2 ± 2.8 and 4.7 ± 1.8 respectively. Further, the dengue in-
fection phases, namely the febrile, critical and recovery
phases were more precisely observed and seen among the
cases of dengue fever without co-infection with leptospi-
rosis. Although the frequency of defervescence phase was
higher in the dengue-leptospirosis group, it was statistically
insignificant. Remarkably, no severe dengue cases were
recorded among the group of dengue co-infected with
leptospirosis.
Association of laboratory results with dengue-
leptospirosis co-infection
The laboratory parameters such as level of aspartate
transaminase (AST), alanine transaminase (ALT), platelet
count, haematocrit and creatine phosphokinase (CPK)
levels were analyzed to identify the possible predictors of
dengue-leptospirosis co-infection (Table 3). However,
there was no significant association found between these
parameters and the dengue-leptospirosis co-infection.
Predictors of dengue-leptospirosis co-infection
Multiple logistic regression analysis was used to identify
the predictors of dengue-leptospirosis co-infection
among the statistically significant parameters and se-
lected parameters with the P value of <0.25 from the
chi-square analysis (Table 2). It was found that the
symptoms of shock has significant predictive value for
dengue-leptospirosis co-infection (Table 4).
Discussion
The study revealed the distribution of the dengue sero-
type among patients admitted to Hospital Serdang in
between 2014-2016 and further analyzed the association
between demographic, clinical and laboratory parame-
ters with dengue-leptospirosis co-infection. During the
period of study, it was found that the DENV 1 was the
most predominant serotype seen in circulation. How-
ever, the circulating dengue serotype pattern in Malaysia
has always been inconsistent and varies among states.
Into details, in 2013, Malaysia experienced an unprece-
dented dengue outbreak which continued to peak in the
year 2014 and 2015. Indescribably, from March 2013
onwards, it was reported that DENV 2 overtook a pre-
existing DENV 4 dominance pattern [10, 11]. A surveil-
lance study conducted by Ministry of Health Malaysia
demonstrated that DENV 1 have replaced DENV 2
twice in 2014 (March and June-December) [11]. Fur-
ther, it has been observed that shift in the dengue sero-
type often causes surge in the number of cases owing
to the reduced herd immunity to the new serotype. A
study conducted at Klang Valley postulated that DENV
1 virus has a cycling pattern of outbreak and suggested
the possibility that it would be selected to be the clade
replacement candidate initiating the next outbreak [12].
Other than that, in the present study, the frequency of
co-infection with leptospirosis was found to be 4.1%. To
our best knowledge, this is a pioneer study conducted to
investigate the incidence rate of dengue-leptospirosis co-
infection in Malaysia by confirmed laboratory tests.
Other studies in Malaysia have reported the prevalence
of either dengue infection or leptospirosis infection and
leptospirosis infection among dengue negative patients.
The incidence of co-infection has also been documented
in other countries such as India, Barbados, Mexico,
Sri-Lanka, Jamaica and Brazil ranging from the year
2000-2015 [6–8, 13–21]. Of these studies, many are
merely individual case–report based and only a coun-
table number have reported concomitant leptospirosis
and dengue infection in a specific population similar
to our study. The findings from our study is impor-
tant as Malaysia is highly endemic for both dengue
and leptospirosis, yet no studies have attempted to in-
vestigate such co-occurrence.
The fundamental reason related to this co-infection was
often referred as random and related to the climate, be-
cause the both diseases peaked during either monsoon sea-
son or heavy rainfall. However, dengue and leptospirosis
Table 1 Serology data for dengue cases suspected for leptospirosis
Total dengue-lepto suspected cases IgM assay (latex agglutination) MAT assay
n = 11 neg (%,n) pos (%, n) neg (%,n) pos (%, n) inconclusive (%,n)
0 (0) 100 (11) 18.2 (2) Titer < 50 27.3 (3) Titer≥ 400 54.5 (6) Titer≥ 50 - < 400
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co-existence need to be confirmed whether it is selective
due to some synergetic reactions or completely random.
Certain literature in-vivo studies had demonstrated that
density and infectivity of virus were enhanced by the co-
infected bacterial reaction [22, 23].
All 11 cases of co-infection of both dengue and lep-
tospirosis were confirmed using laboratory test. The
methods used were real-time PCR and NS1 antigen de-
tection for dengue virus while IgM latex agglutination
and microscopic agglutination test (MAT) were used to
identify leptospira. A positive IgM assay with a positive
(titer ≥ 400) or negative (titer < 50) MAT indicate current
infection of leptospirosis whereas a negative IgM with
positive MAT indicates past infection. Also, MAT is
Table 2 Association of clinical symptoms relative to leptospirosis dengue co-infection
Patient characteristics Dengue-leptospirosis co-infection (n = 11) Dengue infectionwithout leptospirosis (n = 257) P-value*
Age mean (years) 32.3 ± 9.4 30.8 ± 10.8 0.65
Day of fever onset mean (days) 4.2 ± 2.8 4.7 ± 1.8 0.48
Gender Male (%, n) 90.9(10) 57.6(148) 0.03*
Female (%, n) 9.1(1) 42.4(109)
Warning sign Yes (%, n) 36.4(4) 39.7(102) 0.83
No (%, n) 63.6(7) 60.3(155)
Headache Yes (%, n) 0(0) 4.3(11) 0.48
No (%, n) 63.6(7) 95.7(246)
Dengue infection phase febrile 72.0(8) 74.7(192) 0.88
defervescence 27.3(3) 21.0(54)
critical 0(0) 1.6(4)
recovery 0(0) 2.7(7)
Severe dengue Yes (%, n) 0(0) 1.2(3) 0.72
No (%, n) 100(11) 98.8(254)
Arthralgia Yes (%, n) 0(0) 6.6(17) 0.38
No (%, n) 100(11) 93.4(240)
Vomiting Yes (%, n) 9.1(1) 15.6(40) 0.56
No (%, n) 90.9(10) 84.4(217)
Epigastric pain Yes (%, n) 0(0) 7.8(20) 0.34
No (%, n) 100(11) 92.2(237)
Abdominal pain Yes (%, n) 9.1(1) 2.3(6) 0.17*
No (%, n) 90.9(10) 97.7(251)
Retro-orbital pain Yes (%, n) 0(0) 1.2(3) 0.72
No (%, n) 100(11) 98.8(254)
Lethargy Yes (%, n) 9.1(1) 2.7(7) 0.22*
No (%, n) 90.0(10) 97.3(250)
Shock Yes (%, n) 9.1(1) 0.4(1) 0.001*
No (%, n) 90.9(10) 99.6(256)
Acute kidney injury Yes (%, n) 0(0) 0.4(1) 0.84
No (%, n) 100(11) 99.6(256)
Gum bleeding Yes (%, n) 0(0) 2.3 (6) 0.61
No (%, n) 100(11) 97.7(251)
Bleeding tendency Yes (%, n) 0(0) 3.5(9) 0.53
No (%, n) 100(11) 96.5(248)
Hepatitis Yes (%, n) 0(0) 11.7(30) 0.23
No (%, n) 100(11) 88.3(227)
Bold numbers represent significant P value (<0.05)
* Indicates variables with P value <0.25 which were selected for the mutiple logistic regression analysis
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considered as the gold standard test for diagnosis of
leptospirosis. However, although MAT is a high specifi-
city test that detects the total immunoglobulin, it often
shows false negative results reflecting low sensitivity
compared to IgM ELISA / latex agglutination test [24].
A strong positive results indicated by the four-fold rise
in titer between the acute and convalescent phase sam-
ples or seroconversion. In our study, six out of the
eleven IgM positive leptospirosis cases had inconclusive
result for MAT with titer ranged between 50 to <400.
According to the original Faine’s criteria (WHO guide-
line), a MAT titer of >100 can be considered as positive
in low endemicity region, whereas a titer of ≥400 was
the cut-off implied in the high endemicity region [25].
However this criteria was excluded in the modified
Faine’s criteria as it further complicated the final
diagnosis of leptospirosis [26]. Despite that, the data
analysis herein revealed a positive IgM and inconclusive
MAT, which is because of the representative of early
antibody in the current infection with presence of re-
sidual antibody from a past infection. This can be justi-
fied on the ground that over time, the antibody levels
gradually drop following the infection, although low ti-
ters may persist up to 10 years of post-infection. In a
previous study conducted to validate the microsphere
immunoassay and MAT for detection of leptospirosis, it
was found that the microsphere assay is actually reactive
towards the samples with low titers for MAT [27]. There-
fore, it can be confirmed that concurrent serological as-
says are required along MAT for confirmative diagnosis of
leptospirosis.
In an attempt to identify the predictors for dengue-
leptospirosis co-infection, some comparative analyses
are conducted with demographic, clinical, and labo-
ratory parameters between dengue-leptospirosis and
non-leptospirosis groups. Chi-square analysis showed
significant correlation between gender and dengue-
leptospirosis, where male patients are more susceptible
to co-infection compared to female patients. Although
the association of gender for dengue-leptospirosis co-
infection was investigated before, but studies revealed
that male patients had higher risk of dengue and leptospi-
rosis infections when these diseases are present independ-
ently [28, 29]. In Malaysia, summary findings of literatures
from the year 1964 -2016 revealed that the ratio of male
infected with only leptospirosis ranged from 1.9 - 4.3 as
compared to female [30–34]. Meanwhile, our study not
only showed similar trend but male had much higher risk
than female in acquiring co-infection of leptospirosis and
Table 3 Association of laboratory results with dengue- leptospirosis co-infection
Laboratory results Leptospirosis dengue (n = 11) Not leptospirosis-dengue infection (n = 257) P-value*
Type of dengue serotype DENV 1 100(11) 66.1(170) 0.49
DENV 2 0(0) 16.3(42)
DENV 3 0(0) 6.6(17)
DENV 1 + DENV 2 0(0) 7.4(19)
DENV 1 + DENV 3 0(0) 1.9(5)
DENV 2 + DENV 3 0(0) 1.2(3)
DENV 2 + DENV 4 0(0) 0.4(1)
Haematocrit ≥20% increase from baseline Yes (%, n) 18.2(2) 8.6(22) 0.47
No (%, n) 81.8(9) 91.4(235)
Platelet count <100 x 109 /L) Yes (%, n) 18.2(2) 10.5(27) 0.42
No (%, n) 81.8(9) 89.5(230)
ALT Mean (mmol/L) 122.2 ± 88.8 98.33 ± 116.2 0.50
AST Mean (mmol/L) 134.64 ± 81.4 127.39 ± 142.8 0.87
CPK Mean (U/L) 1355.3 ± 1765.4 484.0 ± 1453.638 0.06*
* Indicates variables with P value <0.25 which were selected for the mutiple logistic regression analysis
Table 4 Multiple logistic based regression analysis for predictors
of dengue-leptospirosis co-infection
Clinical variables Exp (B) 95% CI P-value
Lower Upper
Shock: Presence 39.17 1.32 1161.32 0.03
Absence 1.00
Sex: Male 8.86 0.96 81.81 0.05
Female 1.00
Abdominal pain: Presence 2.92 0.55 15.47 0.21
Absence 1.00
Lethargy: Presence 5.34 0.50 56.53 0.16
Absence 1.00
CPK 1.00 1.00 1.00 0.18
Bold numbers represent significant P value (<0.05)
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dengue (10:1). Occupational exposure could be one of the
reasons for male preponderance. Construction sites, se-
wage area, rice field, and sugar cane farms generally con-
sisted of more male workers, where these are the locations
that often deemed for acquiring dengue and leptospirosis
infections. In the present study, the multiple logistic re-
gression reached borderline significance for gender which
can be due to the sample size.
In this study, a wide range of clinical symptoms
were investigated for their association with dengue-
leptospirosis co-infection. Our investigation showed
that patients with the co-infection were significantly
present with shock. However, there was only patient
with shock symptom in the co-infected group. This
patient was referred to the hospital as a case of den-
gue fever with compensated shock and sinus tachycar-
dia. Further laboratory result revealed that the patient
developed warning sign of hemoconcentration and
had underlying diseases which are diabetes and hyper-
cholesterolemia. However patient eventually recovered
from shock after treatment. Other laboratory inspection
revealed positive result for dengue IgM, NS1 antigen,
leptospirosis IgM and inconclusive MAT (titer 1: 200).
Platelet count and CPK level were normal. In this case,
CPK level could not predict leptospirosis. Although statis-
tically significant, we believe that shock as a predictive
factor for dengue-leptospirosis co-infection need be inter-
preted cautiously.
Symptoms including headache, arthralgia, epigastric
pain, retro-orbital pain, gum bleeding, and bleeding ten-
dency were exclusively present for dengue fever cases
without leptospirosis. Therefore, these symptoms are
clear indication for the differentiation of dengue from
leptospirosis. A study had revealed higher correlation of
abdominal pain during leptospirosis infection, while
arthralgia during dengue infection [35]. However, in our
study, only one patient from the co-infected group was
present with abdominal pain, therefore statistically insig-
nificant. In addition, no fatality was documented in all
11 dengue-leptospirosis co-infected patients. These cases
were also diagnosed as classical dengue, on the other
hand, three severe dengue cases were found in the den-
gue infection without leptospirosis group. This data sug-
gests positive outcome on the survival of co-infected
patients provided there is fast and accurate detection of
both pathogens and prompt treatment of patients.
As part of the study, the laboratory parameters did not
reveal any significant value as co-infection predictor.
Nevertheless, a 100% frequency of DENV 1 can be de-
tected among the patients that were infected with both
dengue and leptospirosis. Thus, this finding raised the
question that if mosquitoes carrying a certain dengue
serotype selectively target patients with leptospirosis.
However, since DENV 1 is found at high frequency in our
study and could have elevated the chances of co-infections
with this serotype, thus it is difficult to draw conclusion of
serotype prevalence at this point. There is extremely li-
mited literatures available to correlate dengue serotype
with concomitant leptospirosis and dengue infection
cases. Only one study has reported on the prevalence of
dengue serotype of the patients with leptospirosis co-
infection which was found to be DENV 2 [17]. Similarly,
this result is inconclusive, as the predominant serotype
circulating during the period of the study was DENV 2. In
spite of that, since not many studies have emphasized and
documented the serotype of dengue virus among lepto-
spirosis co-infected patient, we hope that our findings will
trigger interests on further studies related to this.
Another laboratory parameter that ought to be taken
into consideration in an event of dengue-leptospirosis
co-infection is CPK level. CPK has been associated as a
predictor for leptospirosis [36]. The present study inves-
tigated the significance of CPK in dengue-leptospirosis
co-infected cases. Despite that the CPK level was not
significant, the mean CPK in the dengue-leptospirosis
co-infection group is substantially higher (almost tripple)
as compared to the dengue infected group. The insignifi-
cance could be due to small number of co-infected pa-
tients. CPK is commonly raised in patients with
leptospirosis due to myalgia. Additionally myalgia is also
a prominent symptom in dengue infected patients.
Therefore it is postulated that CPK level in dengue-
leptospirosis co-infected patients is expected to be raised
higher than dengue infected patient as a result of ex-
treme myalgia, supported by our findings.
Our current study has several strengths and limitations.
We investigated the prevalence of concurrent dengue and
leptospirosis infections among confirmed dengue patients
and found a total of 11 cases (4.1%) while many other
studies have reported only one to three individual cases or
much lower prevalence compared to our study [6, 8, 13,
15, 16, 18, 20, 21, 37]. In addition, our findings may war-
rant further study to elucidate the occurrence of concur-
rent dengue and leptospirosis infection. Among the
limitations of the current study is lack of robust tool to
detect dengue and leptospirosis simultaneously, neverthe-
less it can be developed in future. Our current study has
focused on one locality only, therefore we suggest future
studies in Malaysia involving bigger study area to draw
strong evidence on occurrence of dengue and leptospirosis
co-infection and the clinical predictors.
Conclusion
In conclusion, patients with dengue fever who suffered
from shock were more likely to be affected from co-
infection compared to patients that did not experience
shock, however this findings need to be treated cautiously
due to the low number of patients presented with shock
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in the current study. Male patients and those who are
infected with DENV 1 might need close monitoring for
co-infection with leptospirosis as there is possibility for
association of gender and dengue serotype with co-
infection. Every possible method is required to enable the
identification of the patients that were at risk of being co-
infected by dengue-leptospirosis. The identification will
lead to further intervention to possibly be instituted.
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